frondoside a

Frondoside A is a natural **triterpenoid glycoside** (specifically, a triterpenoid saponin) extracted from the sea cucumber *Cucumaria frondosa*. It has demonstrated a broad range of **anti-cancer activities** in preclinical research, including induction of apoptosis (programmed cell death), inhibition of cancer cell growth, suppression of cell migration and invasion, inhibition of metastasis, and anti-angiogenic effects. The primary mechanism of action appears to be the **inhibition of p21-activated kinase 1 (PAK1)**, a kinase upregulated in many cancers; there is also evidence it antagonizes **prostaglandin E receptors EP2 and EP4**. Frondoside A has shown synergistic activity with chemotherapeutic agents such as paclitaxel, gemcitabine, and cisplatin. It has been effective in a variety of tumor models including lung, bladder, pancreatic, and breast cancers. Frondoside A displays **high safety** with no significant toxicity observed in animal studies. It is currently an experimental compound, not approved for clinical use, and is derived or manufactured by purification from sea cucumber tissues.[1][3][5][7][8]

Other names

frondoside a hydrate